Cargando…
Comparative study of Revogene GBS LB assay and GeneXpert GBS LB assay for the detection of group B Streptococcus in prenatal screening samples
BACKGROUND: Group B Streptococcal (GBS) infections in the United States are a leading cause of meningitis and sepsis in newborns. The CDC therefore recommends GBS screening for all pregnant women at 35–37 weeks of gestation and administration of intrapartum prophylaxis (in those that tested positive...
Autores principales: | Choera, Tsokyi, Jung-Hynes, Brittney, Chen, Derrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958782/ https://www.ncbi.nlm.nih.gov/pubmed/31937247 http://dx.doi.org/10.1186/s12879-019-4756-y |
Ejemplares similares
-
Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae
por: Han, Meng-Yi, et al.
Publicado: (2021) -
Multicenter Evaluation of the Cepheid Xpert GBS LB XC Test
por: Thwe, Phyu M., et al.
Publicado: (2022) -
A comparison of GenomEra® GBS PCR and GeneXpert ® GBS PCR assays with culture of GBS performed with and without broth pre-enrichment
por: Nielsen, S. Y., et al.
Publicado: (2020) -
Comparison of the Panther Fusion and BD MAX Group B Streptococcus (GBS) Assays for Detection of GBS in Prenatal Screening Specimens
por: Berry, Gregory J., et al.
Publicado: (2019) -
Performance of BD MAX Group B Streptococcus (GBS) Assay without Enrichment for the Detection of GBS
por: Um, Sewhan, et al.
Publicado: (2022)